Gene · 7706
Papers2,924
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,924
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Antiviral regulator TRIM25 as a prognostic marker of better survival in Merkel cell carcinoma: Association with MCPyV status. | Int J Cancer | 2026 | 41689405 | PubTator, text mining | PubMed |
| Multi-Omics Dissection of the Role of Ubiquitination Modification in Post-Stroke Neuroinflammation and Function Damage. | Synapse | 2026 | 41676882 | PubTator, text mining | PubMed |
| Identification of ubiquitination-related signature genes for predicting kidney transplant rejection. | Sci Rep | 2026 | 41667756 | PubTator, text mining | PubMed |
| Structural basis of TACO1-mediated efficient mitochondrial translation. | Nat Commun | 2026 | 41663403 | PubTator, text mining | PubMed |
| The effect of walnut consumption on the peripheral blood mononuclear cell transcriptome. | Genes Nutr | 2026 | 41654725 | PubTator, text mining | PubMed |
| Constant trouble with prolines-navigating a global translation dilemma. | Nucleic Acids Res | 2026 | 41614299 | PubTator, text mining | PubMed |
| Structural resilience of skylights with perforated panels in healthcare facilities: a case study. | Sci Rep | 2026 | 41559365 | PubTator, text mining | PubMed |
| MYC-driven TRIM27 upregulation promotes prostate cancer progression by enhancing CANX ubiquitination and activating PI3K/AKT signaling. | Funct Integr Genomics | 2026 | 41557161 | PubTator, text mining | PubMed |
| Targeting TRIM25 as a therapeutic strategy to enhance ferroptosis in glioblastoma cells. | J Nanobiotechnology | 2026 | 41501880 | PubTator, text mining | PubMed |
| The potential immunological mechanisms of gut microbiota dysbiosis caused by antibiotics exacerbate the lethality of influenza viruses. | Gut Microbes | 2026 | 41481285 | PubTator, text mining | PubMed |
| The Influence of Menstrual Cycle Phase on the Physiological and Perceptual Responses to Low-Intensity Continuous and High-Intensity Interval Sessions in Endurance Trained Women: The FENDURA Project. | Eur J Sport Sci | 2026 | 41420554 | PubTator, text mining | PubMed |
| An fMRI-informed EEG model of the amygdala is associated with salience network dynamics during naturalistic emotional stimulation. | Mol Psychiatry | 2026 | 41398369 | PubTator, text mining | PubMed |
| Neuromedin B and its receptor NMBR inhibit H9N2 infection. | Vet Microbiol | 2026 | 41242095 | PubTator, text mining | PubMed |
| tRNA-Derived Fragment tRF-22 Promotes Immunosuppression by Inhibiting HnRNPAB Ubiquitination in Esophageal Squamous Cell Carcinoma. | Adv Sci (Weinh) | 2026 | 41144758 | PubTator, text mining | PubMed |
| Psychological But Not Motor Performance and Physiological Metrics Are Influenced in Menstrual Cycle Monitoring during Rest and Submaximal Cycling. | Med Sci Sports Exerc | 2026 | 41054001 | PubTator, text mining | PubMed |
| Genomic epidemiology of Helicobacter pylori in regions with high and low risk of gastric cancer, Colombia. | Front Microbiol | 2025 | 41757356 | PubTator, text mining | PubMed |
| Structural Basis of TACO1-Mediated Efficient Mitochondrial Translation. | bioRxiv | 2025 | 41446151 | PubTator, text mining | PubMed |
| DENetwork unveils non-differentially expressed genes with functional relevance across conditions through information flow perturbation. | Nucleic Acids Res | 2025 | 41404797 | PubTator, text mining | PubMed |
| Setting up JBrowse 2 for Visualizing Genome Synteny. | Curr Protoc | 2025 | 41347761 | PubTator, text mining | PubMed |
| LL22NC03-N14H11.1 regulates the m6A modification of MYC and promotes glycolytic activity in hepatocellular carcinoma cells by inhibiting IGF2BP3 ubiquitination degradation. | J Exp Clin Cancer Res | 2025 | 41331843 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7706/papers?page=5